Sichuan Mianzhu Hongji Pharmaceutical Co., Ltd. was founded in 2002 in Mianzhu, Sichuan Province - the hometown of the famous Chinese liquor Jiannanchun. The company is a comprehensive pharmaceutical enterprise holding both a medical device production licence and a drug production licence, mainly engaged in the production and sale of medical devices for injection solutions, blood collection, component separation and storage, together with their matching blood preservation solutions. Its unified social credit code is 91510683738346526R, registered capital is RMB 20 million, the legal representative is Liao Dacheng, and it employs 96 people. The production plant is located on Chengqing Road East, Jiangsu Industrial Park, Mianzhu City, Sichuan Province, covering about 140 mu with a building area of about 45,000 square metres.
The plant comprises an administrative area, a quality inspection centre, a device workshop, a pharmaceutical workshop, device workshops No. 2 and No. 3, a powered medical device workshop, an ethylene oxide sterilisation workshop, a general warehouse, a water station, a gas supply centre, a power distribution station, a maintenance centre and a boiler house, forming a complete production system covering the storage of raw materials and finished products, clean production, sterilisation and finished product inspection. The company organises production and inspection strictly in accordance with good manufacturing practices and approved processes and standards, keeping tight control of quality and taking product quality as its core and customer satisfaction as its goal.
To accelerate development and strengthen competitiveness, the company has established an R&D department with two project divisions for pharmaceuticals and devices. The R&D department has 18 professional technical staff; the discipline leader is a senior engineer with 20 years of product development experience, and the other members all hold college diplomas or above in pharmacy or related fields. The company has also established long-term strategic cooperation covering industry, academia, research and sales with medical colleges and research institutions such as Sichuan Provincial People Hospital, Chengdu University of Traditional Chinese Medicine, Chengdu Yilukang Medical Technology Service Co. and Chongqing 360 Pharmaceutical Co. Guided by high-end market products and products in urgent clinical demand, it is fully advancing the initiation, development, production and sale of new products.
The company currently holds 9 drug approval numbers, all for injections, together with 8 medical device registration certificates - 5 Class III and 3 Class II -mainly in the fields of blood collection and transfusion and plasma collection and processing. Among them, the disposable sterile auto-disable syringe is a utility-model patented product that obtained a medical device registration certificate of the People's Republic of China in July 2022. The company flagship product at present is sodium citrate solution for anticoagulation, whose production line has an annual capacity of 10 million bags, fully meeting market demand.
Since resuming production in May 2017, the company has been actively organising the production of existing products and the construction of large-scale production for new products. At present annual capacity stands at 5 million leucocyte reduction filters, 2 million disposable plastic blood bags, 2 million plasma separators, 150 plasma collection machines and 270 million disposable sterile auto-disable syringes, while medical masks are produced in cleanrooms on four production lines, ensuring an adequate supply of epidemic-prevention materials. The company has established strategic partnerships with domestic biological products companies including Shuyang, Rongsheng, Lanzhou Biological, Wuhan Biological, Shanghai Biological, Jiangxi Boya and Guizhou Zhongtai, providing anticoagulant products over the long term, and has also built sound cooperative relationships with blood centres across Sichuan Province to which it supplies blood bags. Thanks to strong quality awareness, excellent product quality and quality service, the company has won unanimous praise from all its customers.
With the philosophy of "talent as the foundation, science and technology as the support, product quality as the core and customer satisfaction as the goal", the company strives to become a modern, large-scale medical device and pharmaceutical manufacturer that is leading in technology, renowned in brand, excellent in culture and sound in market network, first-class in China and influential internationally. Address: Chengqing Road East, Jiangsu Industrial Park, Mianzhu City, Sichuan Province; Tel: 0838-6100195; Website: www.hongjipharma.com.